The HER2 gene amplification and protein expression of mixed gastric mucinous adenocarcinoma, key points of determination, joint detection, and significance of HER2 gene amplification markers, and sensitivity of chemotherapy drugs have been proposed in previous studies (14–16). Here, ERBB2 is linked to mucinous adenocarcinoma.